Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy and safety of dronabinol MDI
for the acute treatment of moderate to severe migraine headache.